Standout Papers

Sirolimus in patients with clinically active systemic lupus erythematosus resistant to, or intolerant of... 2018 2026 2020 2023 307
  1. Sirolimus in patients with clinically active systemic lupus erythematosus resistant to, or intolerant of, conventional medications: a single-arm, open-label, phase 1/2 trial (2018)
    Zhi‐Wei Lai, Ryan L. Kelly et al. The Lancet
  2. Rab4A-directed endosome traffic shapes pro-inflammatory mitochondrial metabolism in T cells via mitophagy, CD98 expression, and kynurenine-sensitive mTOR activation (2024)
    Nick Huang, Thomas Winans et al. Nature Communications

Immediate Impact

4 by Nobel laureates 21 from Science/Nature 58 standout
Sub-graph 1 of 21

Citing Papers

Ironing out the role of ferroptosis in immunity
2024 Standout
Critical Reanalysis of the Mechanisms Underlying the Cardiorenal Benefits of SGLT2 Inhibitors and Reaffirmation of the Nutrient Deprivation Signaling/Autophagy Hypothesis
2022 Standout

Works of András Perl being referenced

Renal mTORC1 activation is associated with disease activity and prognosis in lupus nephritis
2022
N ‐acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: A randomized, double‐blind, placebo‐controlled trial
2012

Author Peers

Author Last Decade Papers Cites
András Perl 4616 3095 3257 190 9.7k
Carl M. Pearson 1869 4320 2678 179 10.6k
Antonio La Cava 5103 1323 1401 159 9.6k
Ferdinando Nicoletti 3475 871 4434 318 11.5k
K. Frank Austen 6295 2248 2998 198 14.9k
Christoph J. Binder 8776 1428 4939 201 15.5k
Stephen M. Anderton 5968 656 2468 119 10.0k
Gunnar Husby 1527 2397 3537 272 8.1k
Harris Perlman 5162 982 5193 140 11.7k
Per‐Johan Jakobsson 1551 1550 3239 166 9.7k
Masahide Asano 3800 581 4781 165 10.9k

All Works

Loading papers...

Rankless by CCL
2026